Some of largest pharmaceutical, biotech and CRO (contract research organizations) companies are beginning preparations for a summit in May to focus on how to manage quality in the outsourcing of clinical trials.
Vindon says its investments in its Irish and Californian facilities come as pharma companies shift to outsourcing stability storage in order to save costs.
Pfizer, GlaxoSmithKline, Roche and 26 other large pharmaceutical companies will provide about $5.85m (3.5m Euros) over three years to fund an Interpol initiative to combat pharmaceutical counterfeits and crime.
More flexible regulations on the path for approving potential Alzheimer's disease treatments represent a huge opportunity, according to the US FDA, CROs and research advocates.
Positron emission tomography (PET) drug manufacturers have three years to gain NDA or ANDA approval or they must remove their products from the market according to the US FDA.
The positive impact drug industry demand for quality is having on the fine chemicals sector was evident at industry trade show CPhI last month according to expert Jan Ramakers.
The UK Intellectual Property Office (IPO) wants to make it easier to develop drugs in the country by changing the rules relating to patent infringement in clinical trials.
Big Pharma group TransCelerate BioPharma plans to work with regulators and academics to address the bottlenecks that slow the clinical development of biologic drugs.
Outsourcing-Pharma.com presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from RSP, CMC Biologics and the NIH.
Worries about increasing regulatory scrutiny and penalties top the list of API and drugmaker concerns about supply chains according to a survey by contract distributor UPS.
Four of the biggest pharma manufacturing associations are calling for more patient awareness of the burgeoning issue of fake drugs sold on the internet.
An insomnia treatment linked to sleepwalking and sleep driving should stay on the market according to the Australian Therapeutic Good Administration (TGA).
German drug approval and pricing laws are prompting Pharmas to abandon the market says the EFPIA, which has called for ‘urgent action’ to protect innovation and access to medicines.
Outsourcing-Pharma presents its weekly round-up of the latest new rungs on the pharmaceutical career ladder, including news from Icon, ACM, and Penn Pharma.
Outsourcing-Pharma brings you its weekly round-up of the latest appointments in the pharmaceutical industry – and this week we’re reporting from Interphex where exhibitors Covance and Aesica have introduced new faces. More new from Elsevier, ABPI and...
Frontage Laboratories says it is focussing on improving regulatory and GMP compliance in China after signing a $10m (€7.5m) collaboration with drugs maker Fanghui Pharma.
Outsourcing Pharma presents its weekly round-up of the latest new faces and appointments in the pharmaceutical industry, including news from Patheon, CTI and PRECOS.
Russia’s trial sector has largely recovered from the ‘crisis’ created by revision of approval system in 2010, but regulators are still taking too long to OK studies says industry group ACTO.
Outsourcing-Pharma presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Patheon, Wolfe Laboratories, and Premier Research.
in-PharmaTechnololist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Prosonix, GENO, and BioCryst.
Europe’s Innovative Medicines Initiative (IMI) has adopted the Clinical Data Interchange Standards Consortium’s (CDISC) standards for all future projects in a move announced this week.
Seppic has seen a boom in demand for its new natural origin coating agents for pharmaceuticals, which can speed up production time by 50 per cent at lab stage.
Outsourcing Pharma presents its latest round-up of the movers and shakers within the pharmaceutical industry, including news from Icon, Cenduit and BIA.
Outsourcing-Pharma presents its latest round-up of new appointments in the pharmaceutical industry, including news from Acurian, AbelsonTaylor, and Novartis.
Outsourcing-Pharma presents its latest round-up of the latest chops and changes in the pharmaceutical industry, with news from Clinipace, PHT, and Catabis.
Outsourcing-Pharma presents its round-up of the latest movements within the pharmaceutical industry, including news from Spectrum, ProtAffin AG, Biogen Idec, and Prosonix.
